معرفی
Dominik Fischer is a Professor of Ophthalmology at the University of Tübingen and University of Lausanne, with an affiliation at the Nuffield Laboratory of Ophthalmology and Oxford Eye Hospital. He is a Consultant Ophthalmic Surgeon specializing in retinal diseases and their gene therapy treatments. His clinical training spans the University of Pennsylvania, University of Tübingen, and University of Oxford.
- Undergraduate training: Munich, Melbourne, Zurich
- Clinical/research training: Pennsylvania, Tübingen, Oxford
Research Interests focus on translational approaches for blinding disorders, including:
- World's first post-approval safety study for ocular gene therapy
- Investigation of innate immune responses to viral vectors in the eye
- Development of CRISPR for GUCY2D dystrophies
- Usher syndrome gene therapy development
- Characterization of transgenic pig models for retinal dystrophy
- World's first PDE6A retinitis pigmentosa clinical trial
- Trials for choroideremia and X-linked retinitis pigmentosa
Scientific Awards:
- Leonhard Klein Award for vitreoretinal surgery advancements
- Senator-Hermann-Wacker Award for retinal/choroidal research
Academic Contributions: Over 70 peer-reviewed articles and 100+ invited lectures. Collaborates with Robert MacLaren, Jasmina Kapetanovic, and Susan Downes. Supervises 9 graduate students focused on retinal therapies.
۰مقاله ثبتشده
